New Study from StrategyR Highlights a $2.3 Billion Global Market for Induced Pluripotent Stem Cell (iPSC) by 2026

/PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled...

Related Keywords

Germany ,Australia ,Japan ,United States ,India ,United Kingdom ,Singapore ,China ,Italy ,Canada ,South Korea ,France ,America ,Zak Ali ,Fujifilm ,Axol Bioscience Ltd ,Fate Therapeutics Inc ,United States Inc ,Viacyte Inc ,Takara Bio Inc ,Other Research Methods ,Research Method Cellular ,Cynata Therapeutics ,Application Drug Development Toxicology Testing ,Academic Research ,Marketglass Research Platform ,Corporate Communications ,Thermo Fisher Scientific Inc ,Our Expert Panel ,Cellular Dynamics Inc ,Sumitomo Dainippon Pharma Co Ltd ,Global Industry Analysts Inc ,Marketglass Research ,Cynata Therapeutics Limited ,Fate Therapeutics ,Pluricell Biotech ,Takara Bio ,Thermo Fisher Scientific ,Cell Type ,Vascular Cells ,Cardiac Cells ,Neuronal Cells ,Liver Cells ,Immune Cells ,Research Method ,Cellular Reprogramming ,Cell Culture ,Cell Differentiation ,Cell Analysis ,Cellular Engineering ,Drug Development ,Toxicology Testing ,Regenerative Medicine ,Project Preview ,Induced Pluripotent Stem Cell ,While China ,Cells Segment ,Global Industry Analysts ,Industry Analysts ,Nc ,